14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $12.77 $17.80 Tuesday, 23rd Apr 2024 ENTA stock ended at $13.15. This is 2.16% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 5.14% from a day low at $13.04 to a day high of $13.71.
90 days $11.01 $17.80
52 weeks $8.08 $37.75

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
Mar 18, 2024 $14.48 $14.48 $13.49 $13.51 110 580
Mar 15, 2024 $13.80 $14.37 $13.71 $14.21 181 010
Mar 14, 2024 $14.37 $14.56 $13.74 $13.86 96 593
Mar 13, 2024 $14.45 $14.79 $14.37 $14.44 165 948
Mar 12, 2024 $15.08 $15.08 $14.51 $14.54 113 122
Mar 11, 2024 $15.40 $15.67 $15.02 $15.08 70 955
Mar 08, 2024 $15.83 $16.23 $15.09 $15.40 159 542
Mar 07, 2024 $15.45 $16.05 $15.45 $15.72 181 934
Mar 06, 2024 $15.06 $15.70 $14.99 $15.66 140 216
Mar 05, 2024 $15.65 $16.03 $14.66 $15.06 236 152
Mar 04, 2024 $15.48 $15.80 $15.06 $15.65 238 203
Mar 01, 2024 $14.45 $15.68 $14.19 $15.35 321 016
Feb 29, 2024 $14.35 $14.71 $14.10 $14.37 180 335
Feb 28, 2024 $14.04 $14.59 $13.92 $14.30 198 830
Feb 27, 2024 $14.23 $14.42 $13.88 $14.05 233 643
Feb 26, 2024 $13.46 $14.19 $13.46 $14.04 195 551
Feb 23, 2024 $12.58 $13.50 $12.53 $13.46 191 723
Feb 22, 2024 $12.80 $13.01 $12.27 $12.51 257 242
Feb 21, 2024 $12.80 $13.03 $12.78 $12.98 98 526
Feb 20, 2024 $12.85 $13.14 $12.72 $12.79 194 232
Feb 16, 2024 $13.14 $13.36 $12.94 $12.99 205 753
Feb 15, 2024 $13.43 $13.84 $13.16 $13.26 322 608
Feb 14, 2024 $12.52 $13.39 $12.30 $13.21 245 020
Feb 13, 2024 $11.96 $12.40 $11.92 $12.31 340 344
Feb 12, 2024 $12.38 $12.58 $12.24 $12.33 362 696
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT